Host: The Japanese Society of Toxicology
Our recent studies have shown that the co-administration of nicotinamide (NAM), a precursor of methylnicotinamide (MNA), with S-adenosylmethionine (SAM) and hydralazine (HYD) significantly improves fatty liver in a rat model of NAFL. In this study, we conducted the in vitro metabolism studies using hepatic homogenate prepared from NAFL rats to explore some of the mechanisms of fatty liver improvement by NAM. Consequently, it was suggested that the combined administration of SAM and HYD efficiently increases the hepatic MNA exposure and led to the improvement of fatty liver in rats.